• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Assessment Of R&D For Rapid Vaccine Development And Production In Asia

tetano

Editor, Senior Moderator
Workshop

Under sponsorship by NSF and other Federal agencies, the World Technology Evaluation Center, Inc. (WTEC), the nation's leading organization for conducting international technology assessments, has commissioned a panel of U.S. experts to complete a study started in 2007 on the worldwide advances in Vaccine Development and Production. Previously the United States and Europe were analyzed; now Asia is the focus in this phase.

Results will be presented in a FREE workshop to be held on May 5, 2010, 8:30am - 4:00pm, at the National Science Foundation (NSF), 4201 Wilson Boulevard, Stafford II, Room 555, Arlington, VA, 22230. Although the workshop is free, registration is required.

Register to the workshop

Introduction

The swine flu pandemic of spring 2009 has reminded everyone of the threat of such worldwide disease. Although this pandemic seems to be receding at this writing, it may return in the winter with a vengeance as the Spanish Flu did in 1918. This threat and the continuing danger of greater human transmission of avian influenza has brought to the fore the pressing need for advances in rapidly responsive vaccine development, production, and distribution. According to a National Academy of Sciences Report, identification of a viral strain may take as long as six to eight months with additional months required to produce and distribute effective vaccines. Standard methods for production of vaccines were developed more than 50 years ago. Many modern methods, materials, and processes can enable improvement of the present situation. The solution to providing a rapid response with the production and deployment of therapeutic immunization requires cross-cutting research in manufacturing, biomedical engineering, systems modeling and other disciplines, as well as quality standards, clinical testing, and education of responders and the general public.
......

http://www.medicalnewstoday.com/articles/184198.php
 
Back
Top Bottom